Lincoln National Corp (LNC) does not present a compelling buy opportunity for a beginner, long-term investor at this time. The financial performance shows significant declines, insider selling has increased drastically, and analysts have generally lowered their price targets. While technical indicators are neutral and options data suggests a slightly bearish sentiment, there are no strong positive catalysts to justify an immediate buy.
The MACD is positive at 0.247 but contracting, RSI is neutral at 56.805, and moving averages are converging, indicating no clear trend. The stock is trading near its pivot level of 35.768, with resistance at 37.193 and support at 34.343. Overall, the technical indicators suggest a neutral stance.

NULL identified. No recent news or significant positive developments. Wells Fargo's earlier upgrade to Overweight with a $48 price target is a positive note but is offset by other negative factors.
Insiders are selling, with a 375.63% increase in selling activity over the last month. Analysts have consistently lowered price targets, citing challenges in the life insurance sector and economic uncertainty. Financial performance has significantly deteriorated, with revenue, net income, and EPS all showing substantial YoY declines.
In Q4 2025, revenue dropped 16.29% YoY to $5.32 billion, net income fell 55.67% YoY to $743 million, and EPS declined 60.54% YoY to 3.8. Gross margin remained flat. These figures indicate a significant decline in financial health.
Analysts have generally lowered price targets. BofA, UBS, Mizuho, and Barclays have all reduced targets, with ratings ranging from Neutral to Outperform. The most recent target is $37, close to the current pre-market price of $36.46, suggesting limited upside potential in the near term.